Vivos Therapeutics (VVOS) Cash & Equivalents (2019 - 2026)
Vivos Therapeutics' Cash & Equivalents was $1.8 million in Q2 2026, down 59.1% from $4.4 million a year earlier and down 14.7% from the prior quarter.
Vivos Therapeutics (VVOS) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Vivos Therapeutics came in at $2.03 million, down 67.6% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of -35.5% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $6.26 million in FY2024 (+281.0%), $1.64 million in FY2023 (-53.3%), $3.52 million in FY2022 (-85.4%) and $24.03 million in FY2021 (+32.0%).
- The Q2 2026 figure marks the lowest quarterly Cash & Equivalents since Q4 2023.
- Compared with a year earlier, Cash & Equivalents has declined for six straight quarters, with growth averaging 72.3% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was Q3 2024 (growth of 531.1%); the worst was Q4 2022 (a decline of 85.4%).
- Per Business Quant data, VVOS's Cash & Equivalents in the three quarters before Q2 2026 was $2.11 million (Q1 2026), $2.03 million (Q4 2025) and $3.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn | 4.06 Bn |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn | 5.10 Bn |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn | 4.35 Bn |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn | 2.76 Bn |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn | 1.69 Bn |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn | 3.39 Bn |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn | 539.00 Mn |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn | 2.91 Bn |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn | 708.00 Mn |
| 10 | Vivos Therapeutics | 2.18 Mn | -7.03 Mn | 2.95 Mn | 1.80 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.80 Mn |
| Mar 31, 2026 | 2.11 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Sep 30, 2025 | 3.10 Mn |
| Jun 30, 2025 | 4.40 Mn |
| Mar 31, 2025 | 2.34 Mn |
| Dec 31, 2024 | 6.26 Mn |
| Sep 30, 2024 | 6.31 Mn |
| Jun 30, 2024 | 6.90 Mn |
| Mar 31, 2024 | 2.61 Mn |
| Dec 31, 2023 | 1.64 Mn |
| Sep 30, 2023 | 1.00 Mn |
| Jun 30, 2023 | 3.94 Mn |
| Mar 31, 2023 | 7.05 Mn |
| Dec 31, 2022 | 3.52 Mn |
| Sep 30, 2022 | 6.72 Mn |
| Jun 30, 2022 | 12.70 Mn |
| Mar 31, 2022 | 17.83 Mn |
| Dec 31, 2021 | 24.03 Mn |
| Sep 30, 2021 | 28.53 Mn |
Vivos Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VVOS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "VVOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VVOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();